BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/20/2015 1:07:00 PM | Browse: 1099 | Download: 1938
 |
Received |
|
2014-05-29 10:34 |
|
Peer-Review Started |
|
2014-05-29 13:20 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-06-19 14:11 |
|
Revised |
|
2014-07-03 02:23 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-11-12 13:43 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-11-19 11:05 |
|
Articles in Press |
|
2014-11-19 11:06 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-01-16 13:52 |
|
Publish the Manuscript Online |
|
2015-01-20 11:01 |
| ISSN |
2218-6239 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Svetlana V Kyosseva and James F McGinnis |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| NIH NEI |
R21EY018306 |
| NIH NEI |
R01EY18724 |
| NIH NEI |
R01EY022111 |
| National Science Foundation |
CBET-0708172 |
|
| Corresponding Author |
Svetlana V Kyosseva, PhD, Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, AR 72205, United States. svkiosseva@uams.edu |
| Key Words |
Nanoceria; Age-related macular degeneration; Inherited retinal degeneration; Oxidative stress; Antioxidant |
| Core Tip |
This review outlines the recent findings that cerium oxide nanoparticles (nanoceria) may represent novel and broad spectrum therapeutic agents to treat retinal diseases including age-related macular degeneration, retinal angiomatous, inherited retinal degeneration, and fight inflammation and pathologies associated with oxidative stress.
|
| Publish Date |
2015-01-20 11:01 |
| Citation |
Kyosseva SV, McGinnis JF. Cerium oxide nanoparticles as promising ophthalmic therapeutics for the treatment of retinal diseases. World J Ophthalmol 2015; 5(1): 23-30 |
| URL |
http://www.wjgnet.com/2218-6239/full/v5/i1/23.htm |
| DOI |
http://dx.doi.org/10.5318/wjo.v5.i1.23 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
